|
MAGED2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11249995274443E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.28779999997164E-07 |
| Normal-vs-Stage2 |
2.176200E-04 |
| Normal-vs-Stage3 |
4.030900E-04 |
| Normal-vs-Stage4 |
8.29340000008116E-07 |
| Stage1-vs-Stage2 |
4.410400E-01 |
| Stage1-vs-Stage3 |
4.287400E-01 |
| Stage1-vs-Stage4 |
1.458020E-01 |
| Stage2-vs-Stage3 |
8.784200E-01 |
| Stage2-vs-Stage4 |
6.413200E-01 |
| Stage3-vs-Stage4 |
7.937400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.56719997984811E-09 |
| Normal-vs-AfricanAmerican |
2.937300E-03 |
| Normal-vs-Asian |
3.577500E-04 |
| Caucasian-vs-AfricanAmerican |
3.837200E-01 |
| Caucasian-vs-Asian |
4.217400E-01 |
| AfricanAmerican-vs-Asian |
1.972230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.22379997433842E-09 |
| Normal-vs-Female |
4.7803000002844E-07 |
| Male-vs-Female |
3.442200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.683900E-02 |
| Normal-vs-Age(41-60Yrs) |
2.23249999999897E-05 |
| Normal-vs-Age(61-80Yrs) |
2.55550025585194E-10 |
| Normal-vs-Age(81-100Yrs) |
2.06799999999951E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.697000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.552780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.399800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.491200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.498400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.256000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.148800E-01 |
| Normal-vs-Grade 2 |
2.27220000004191E-06 |
| Normal-vs-Grade 3 |
4.75060000004746E-07 |
| Normal-vs-Grade 4 |
1.28710375690844E-11 |
| Grade 1-vs-Grade 2 |
2.451800E-02 |
| Grade 1-vs-Grade 3 |
9.961400E-03 |
| Grade 1-vs-Grade 4 |
1.361450E-04 |
| Grade 2-vs-Grade 3 |
1.231370E-01 |
| Grade 2-vs-Grade 4 |
1.636610E-04 |
| Grade 3-vs-Grade 4 |
6.345500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.83369985862214E-10 |
| Normal-vs-ccB subtype |
2.405000E-04 |
| ccA subtype-vs-ccB subtype |
6.265800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.12400000044033E-07 |
| Normal-vs-N1 |
9.19949999511616E-08 |
| N0-vs-N1 |
4.031800E-02 |
|
|
